News - Latest
95 news items
New layout of the MEB website
Starting today, the website of the Medicines Evaluation Board (MEB) has a new layout. This makes the website more user-friendly ...
Year-end withdrawals
Requests for withdrawal on December 31st (the year-end withdrawals) should be received by the Medicines Evaluation Board (MEB) on ...
MEB and Swissmedic sign Memorandum of Understanding
The Medicines Evaluation Board (MEB) intends to intensify collaboration with its partner authority in Switzerland in the field of ...
Brexit: fully prepared
The United Kingdom (UK) is leaving the European Union. The terms on which the UK is going to leave the EU are still unclear. The ...
5th issue of the digital Regulatory Science Magazine
The 5th issue of the Medicines Evaluation Board’s Regulatory Science Magazine is now available. This issue focuses on ...
Information about the Falsified Medicines Directive (FMD)
Update for marketing authorisation holders The Falsified Medicines Directive (FMD) (Directive 2011/62/EU) are measures to prevent ...
Opportunities for innovation, challenges for regulations
Review of 2018 MEB Day Innovation and quick and careful registration. How do we make sure that regulations do not get too much in ...
Amended policy for DHPCs and national implementation of additional risk minimisation measures
The Medicines Evaluation Board (MEB) has amended its policy for Direct Healthcare Professional Communications (DHPCs) and the ...
The fourth issue of Regulatory Science Magazine is being launched today
The fourth issue of the Medicines Evaluation Board’s Regulatory Science Magazine is appearing today. The focus this time is on ...
MEB and Dutch Heart Foundation to collaborate on making medicines available to the patient more quickly
Scientific advice from the MEB improves and speeds up the development of medicines The Medicines Evaluation Board (MEB) is going ...